<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">666432</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2021.666432</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Network Pharmacology-Based Validation of the Efficacy of <italic>Huiyangjiuji</italic> Decoction in the Treatment of Experimental Colitis</article-title>
<alt-title alt-title-type="left-running-head">Yu et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Huiyangjiuji decoction in ulcerative colitis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Wei</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheng</surname>
<given-names>Hongju</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Baoliang</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yan</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1119494/overview"/>
</contrib>
</contrib-group>
<aff>Department of Physiology, Jining Medical University, <addr-line>Jining</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/561129/overview">Tao Xu</ext-link>, Anhui Medical University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/586734/overview">Padhmanand Sudhakar</ext-link>, KU Leuven, Belgium</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/97727/overview">Maikel Peppelenbosch</ext-link>, Erasmus Medical Center, Netherlands</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jing Yan, <email>yanjing102@mail.jnmc.edu.cn</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>05</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>666432</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>02</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>05</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Yu, Cheng, Zhu and Yan.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Yu, Cheng, Zhu and Yan</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Ulcerative colitis (UC) is the major type of inflammatory bowel disease (IBD) characterized by an overactive immune responses and destruction of the colorectal epithelium with intricate pathological factors. In China, <italic>Huiyangjiuji</italic> decoction (HYJJ) has been widely administered against inflammation, but the underlying mechanical mechanisms are not known. A murine model of colitis was established by orally feeding 4% dextran sodium sulfate for 5&#xa0;days. Intestinal organoids (IOs) were treated with TNF&#x3b1; (Tumor necrosis factor-&#x3b1;) as an <italic>ex-vivo</italic> UC model. A scratch assay combined with a co-culture system that incubated murine epithelial cell line (IEC-6) with macrophages (M&#x3c6;s) was utilized to assess epithelial recovery under inflammatory conditions. Network pharmacology analysis was performed to elucidate the mechanism of HYJJ decoction. In the present study, we confirmed that HYJJ considerably alleviated of DSS-induced colitis, as evidenced by the improved intestinal injury and fecal albumin, as well as feces blood. Network pharmacology analysis identified the active components in HYJJ formula, and KEGG enrichment analysis indicated that HYJJ-target genes were enriched in pathogen-induced infections, cancer-related as well as inflammatory pathways. Consistently, RNA-sequencing demonstrated that HYJJ treated inhibited cytokine-cytokine interaction, IBD as well as TNF signaling pathways, confirming the anti-inflammatory and anti-neoplastic role of HYJJ decoction. <italic>In-vitro</italic> experimental evidence confirmed the suppression of pro-interleukins by HYJJ, including IL-2, IL-10 and IL-12. Moreover, the contribution of HYJJ to mucosal healing was corroborated by <italic>ex-vivo</italic> experiments, in which HYJJ rescued TNF&#x3b1;-compromised IOs functions, i.e.,&#x20;elevated mitochondrial stress (MOS) and impaired regeneration capacity. IEC-6 cells co-culture with M&#x3c6;s from HYJJ-treated experimental colitis mice showed an improved migration capacity as compared to those incubated with M&#x3c6;s from untreated colitis mice. We conclude that HYJJ re-establishes homeostasis of the gut epithelium during colitis by suppressing inflammation and orchestrating cytokines interaction.</p>
</abstract>
<kwd-group>
<kwd>inflammatory bowel disease</kwd>
<kwd>macrophages</kwd>
<kwd>intestinal organoids</kwd>
<kwd>
<italic>Huiyangjiuji</italic> decoction</kwd>
<kwd>ulcerative colitis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Traditional Chinese Medicine (TCM) has aroused great attention due to the abundance of multiple compounds with proven clinical efficacy that have multitarget properties. However, there are concerns worldwide regarding the efficacy and toxicity of TCM due to inadequate pharmacological evidence. Given that efficacy and toxicity are always the major sources of attrition in TCM, network pharmacology provides the promise of elucidating the mechanical mechanisms of TCM by a more holistic approach for integrating compound-target interactions from a molecular to system&#x20;level.</p>
<p>It has long been known that the pathogenesis of Inflammatory bowel disease (IBD) involves a broad spectrum of factors. In addition to the contribution of genetic variants to the heterogeneity of IBD (<xref ref-type="bibr" rid="B46">Voskuil et&#x20;al., 2020</xref>), physiological environmental dimension, e.g., ingestion and psychological condition also influence the progression (<xref ref-type="bibr" rid="B44">van der Giessen et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B7">Borren et&#x20;al., 2020</xref>). Moreover, these different factors are interlinked and regulate gut microbiome and host-microbiota interaction, hence acting on modulation of IBD pathogenesis (<xref ref-type="bibr" rid="B22">Jazayeri et&#x20;al., 2017</xref>). As of today, the pathogenesis remains still a matter of discussion due to the unpredictable and heterogeneous clinical course of IBD (<xref ref-type="bibr" rid="B46">Voskuil et&#x20;al., 2020</xref>). IBD is pathologically characterized by epithelium disruption under a sustained pro-inflammatory microenvironment, and has two main forms-Crohn&#x2019;s disease (CD) and Ulcerative colitis (UC). CD can induce lesions alongside all the gastrointestinal system, i.e.,&#x20;from mouth to anus, whereas UC is generally limited to the colon (<xref ref-type="bibr" rid="B45">Veauthier and Hornecker, 2018</xref>). UC is an independent risk factor for the progression of colorectal cancer (CRC) (<xref ref-type="bibr" rid="B52">Xue et&#x20;al., 2018</xref>), and UC-associated CRC has a much poorer survival probability as compared to sporadic CRC (<xref ref-type="bibr" rid="B23">Jess et&#x20;al., 2006</xref>). Mucosal healing, one primary concern when developing a potential therapeutic target for UC, requires homeostasis of the intestinal stem cells (ISCs) niche. Any disruption in the ISC niche will destroy the renewal of epithelium, thereby causing gastrointestinal disease (<xref ref-type="bibr" rid="B29">Merlos-Su&#xe1;rez et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B38">Suzuki et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B56">Yu et&#x20;al., 2020</xref>). Herewith, establishing an anti-inflammatory microenvironment in favor of ISC-initiated wound healing and restoring healthy gut function would be an ideal therapeutic strategy, and thus the multitarget nature of TCM would shed light on UC therapy in the clinic.</p>
<p>
<italic>Huiyangjiuji</italic> decoction (HYJJ) formula from Shang Han Lun that is the oldest Chinese monograph on Cold Damage Diseases (<xref ref-type="bibr" rid="B10">Chen et&#x20;al., 2009</xref>), encompasses <italic>Aconitum carmichaelii debx</italic> (ACD), <italic>Zingiberis Rhizoma</italic> (ZR), <italic>Panax Ginseng C. A. Mey</italic> (PGM)<italic>, Glycyrrhiza uralensis Fisch</italic> (GF)<italic>, Atractylodes Macrocephala Koidz</italic> (AMK), <italic>Cinnanmomi Cortex</italic> (CC), <italic>Citrus Reticulata</italic> (CR), <italic>Schisandrae Chinensis Fructus</italic> (SCF), <italic>Poria Cocos (Schw.) Wolf</italic> (PCW)<italic>, Pinellia ternate</italic> (Thunb.) Breit (PB)<italic>.</italic> Among these herbs, the combination of ACD, ZR and GF also termed by Si-Ni decoction has shown proven efficacy for septic shock (<xref ref-type="bibr" rid="B11">Chen et&#x20;al., 2011</xref>), sepsis (<xref ref-type="bibr" rid="B8">Brislinger et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B57">Zeng et&#x20;al., 2019</xref>) by interfering with apoptosis and inflammatory responses (<xref ref-type="bibr" rid="B2">Aly et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B15">Endo et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B53">Yang et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B16">Endo et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B5">Bai et&#x20;al., 2020</xref>). In the context of SI-NI decoction, the anti-inflammatory function has been emphasized by the addition of PGM (<xref ref-type="bibr" rid="B24">Jin et&#x20;al., 2020</xref>), PB (<xref ref-type="bibr" rid="B42">Tian et&#x20;al., 2020</xref>), SCF (<xref ref-type="bibr" rid="B32">Panossian &#x26; Wikman, 2008</xref>; <xref ref-type="bibr" rid="B27">Li et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B28">Li et&#x20;al., 2021</xref>), PCW (<xref ref-type="bibr" rid="B58">Zhang et&#x20;al., 2018</xref>) as well as CC (<xref ref-type="bibr" rid="B13">Csikos et&#x20;al., 2020</xref>). Moreover, focusing on the impaired gastrointestinal functions, AMK is included to improve gastrointestinal motility (<xref ref-type="bibr" rid="B60">Zhu et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B54">Yang et&#x20;al., 2019</xref>) and restore immune homeostasis (<xref ref-type="bibr" rid="B50">Xiang et&#x20;al., 2020</xref>), while CR maintains homeostasis of the gut microbiota (<xref ref-type="bibr" rid="B12">Chen et&#x20;al., 2020</xref>) and inhibits inflammation (<xref ref-type="bibr" rid="B20">Ho &#x26; Lin, 2008</xref>; <xref ref-type="bibr" rid="B19">Herath et&#x20;al., 2016</xref>). Combining various anti-inflammatory herbs with gut-friendly components has offered a promising therapeutic alternative for gut diseases, especially for UC and UC-CRC.</p>
<p>In the present study, we discussed the potential therapeutic effect of HYJJ in UC by network pharmacology combined with RNA-sequencing, and examined the influence of HYJJ <italic>in vivo</italic> and <italic>in&#x20;vitro</italic>.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Ethics Statement</title>
<p>All procedures and assays were approved by the Institutional Animal Care and Use Committee of Jining Medical University.</p>
</sec>
<sec id="s2-2">
<title>Screening of Active Ingredients and Targeted Genes in <italic>Huiyangjiuji</italic> Decoction Components</title>
<p>We screened the active components according to Oral bioavailability (OB) values and drug-likeness (DL) utilizing Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) (<xref ref-type="bibr" rid="B34">Ru et&#x20;al., 2014</xref>). The ingredients greater or equal to 0.1 (Drug likeness, DL) and 20% (OB) were included according to TCMSP parameter information and criteria.</p>
<p>The targets of each active ingredient in HYJJ were retrieved from TSMSP database and transformed into gene symbols of <italic>Homo sapiens</italic> species by the UniProt knowledge database (<ext-link ext-link-type="uri" xlink:href="http://www.uniport.org/">www.uniport.org</ext-link>).</p>
</sec>
<sec id="s2-3">
<title>Inflammatory Bowel Disease-Related Genes Acquisition</title>
<p>We collected IBD-related genes from five sources with the keyword &#x201c;ulcerative colitis,&#x201d; including GeneCards (<xref ref-type="bibr" rid="B33">Rebhan et&#x20;al., 1997</xref>; <xref ref-type="bibr" rid="B35">Safran et&#x20;al., 2010</xref>), DrugBank (<xref ref-type="bibr" rid="B49">Wishart et&#x20;al., 2018</xref>), Online Mendelian Inheritance in Man (OMIM) (<xref ref-type="bibr" rid="B18">Hamosh et&#x20;al., 2002</xref>), PharmGkb (<xref ref-type="bibr" rid="B48">Whirl-Carrillo et&#x20;al., 2012</xref>), and Statistics of Therapeutic Target Database (TTD) (<xref ref-type="bibr" rid="B47">Wang et&#x20;al., 2020</xref>) (<xref ref-type="sec" rid="s11">Supplementary Table&#x20;S1</xref>).</p>
</sec>
<sec id="s2-4">
<title>Establishment of the Herb&#x2013;Ingredient&#x2013;Target Interaction Network</title>
<p>We intersected the targeted genes of HYJJ decoction with disease genes (<xref ref-type="sec" rid="s11">Supplementary Table&#x20;S4</xref>), and constructed a Venn diagram. By Cytoscape software (<xref ref-type="bibr" rid="B37">Su et&#x20;al., 2014</xref>) Herb&#x2013;Ingredient&#x2013;Target (HIT) interaction network was visualized.</p>
</sec>
<sec id="s2-5">
<title>Protein-Protein-Interaction Network Construction</title>
<p>STRING database (Search Tool for Retrieval of Interacting Genes/Proteins) (<ext-link ext-link-type="uri" xlink:href="http://string-db.org/">http://string-db.org/</ext-link>) (<xref ref-type="bibr" rid="B39">Szklarczyk et&#x20;al., 2019</xref>) was used to construct a protein-protein interaction (PPI) network based on the obtained HIT gene symbols. Full PPI network with both functional and physical protein associations and without disconnected nodes was constructed with a confidence score of &#x2265;0.7 for significance.</p>
<p>Network nodes represent proteins, and edges represent protein-protein associations that proteins jointly contribute to a shared function, but this does not mean they are physically binding each other. The thicker of edge means the higher edge confidence.</p>
</sec>
<sec id="s2-6">
<title>Hub-Genes Identification</title>
<p>Hub genes with a high-degree node were identified by Cytocape plugin CytoNCA according to betweenness centrality (BC), closeness centrality (CC), degree centrality (DC), eigenvector centrality (EC), local average connectivity (LAC) and network centrality (NC) (<xref ref-type="bibr" rid="B40">Tang et&#x20;al., 2015</xref>). These features were calculated twice to establish the final sub-network consisting of hub-genes with higher than the median values of the features.</p>
</sec>
<sec id="s2-7">
<title>GO and KEGG Pathway Enrichment</title>
<p>GO (<xref ref-type="bibr" rid="B4">Ashburner et&#x20;al., 2000</xref>) and KEGG enrichment analysis (<xref ref-type="bibr" rid="B26">Kanehisa and Goto, 2000</xref>) of genes were implemented by Bioconductor (R). GO terms with adjusted <italic>p</italic>-value below 0.05 were considered as significantly enriched&#x20;genes.</p>
</sec>
<sec id="s2-8">
<title>Experimental Validation</title>
<sec id="s2-8-1">
<title>Animal</title>
<p>C57BL/6 mice were purchased (Cyagen, China). All animals were housed at sperm free animal facility at Jining medical university. All procedures involving animals were conducted within IACUC guidelines under approved protocols.</p>
</sec>
<sec id="s2-8-2">
<title>Ulcerative Colitis Mouse Model Subjected to <italic>Huiyangjiuji</italic> Decoction Administration</title>
<p>ACD, ZR, PAM, GF, AMK, CC, CR, SCF, PCW, PB were mixed according to the ratio of 3:2:2:3:3:1:2:1:3:3. The mixture was added to 1000&#xa0;ml (1:10&#xa0;g/v) of pure water and boiled for 1&#xa0;h.</p>
<p>A total of 18 mice were randomly divided into three groups (6 per group): control group, DSS group, HYJJ-treated DSS group. 4% dextran sodium sulfate (DSS, MP Biomedicals) was added to drinking water for 4&#xa0;days. Upon removal on day 5, HYJJ decoction solution was administered for 1&#xa0;week. UC was scored by the following standards: i) weight loss (no loss &#x3d; 0; &#x3c;5% &#x3d; 1; 5&#x2013;10% &#x3d; 2; 10&#x2013;20% &#x3d; 3; &#x3e;20% &#x3d; 4); ii) stool (normal &#x3d; 0; soft, watery &#x3d; 1; very soft, semi-formed &#x3d; 2; liquid, sticky, or unable to defecate &#x3d; 3); iii) bloody stool test (no blood test positive within 2&#xa0;min &#x3d; 0; purple positive after 10&#xa0;s &#x3d; 1; light purple positive within 10&#xa0;s &#x3d; 2; heavy purple positive within 10&#xa0;s &#x3d; 3) (Leagene); iv) Histological injury and inflammation were scored by parameters including edema, destruction of the epithelial monolayer, crypt loss, infiltration of immune cells into the mucosa.</p>
<p>Tissues were fixed and then embedded in paraffin. 3&#xa0;&#x3bc;m slice was sections stained with hematoxylin and eosin (H&#x26;E).</p>
</sec>
<sec id="s2-8-3">
<title>Identification of the Chemical Constituents of <italic>Huiyangjiuji</italic> Decoction</title>
<p>Hybrid Quadrupole-TOF LC/MS/MS Mass Spectrometer was utilized. 0.1&#xa0;g decoction powder was added to 1&#xa0;ml 80% methanol under ultrasonication for 15&#xa0;min. After 1200&#xa0;r/min centrifugation for 10&#xa0;min, the filtrate was collected through a 0.45&#xa0;&#x3bc;m membrane filter and injected into Hybrid Quadrupole time-of-flight LC/MS/MS Mass Spectrometer (Triple TOF 5600&#x2b;, AB Sciex Instruments) to identify the chemical constituents.</p>
<p>Chemical identification was performed on a connected system of LC-30 (Shimadzu)-Hybrid Quadruple time-of-flight mass spectrometer (TOF MS) with electrospray ionization source (ESI). InerSustain C18 column (Shimadzu, 100&#x20;mm &#xd7; 2.1&#xa0;mm, 2&#xa0;&#xb5;m) was used to perform chromatographic separation with a flow rate of 0.3&#xa0;ml/min at 35&#xb0;C. A linear gradient program with mobile phase system including Equate A (acetonitrile) and Equate B (0.1% HCOOH-H<sub>2</sub>O): 4&#xa0;min (A:5%:B:95%), 8&#xa0;min (A:20%:B:80%), 2&#xa0;min (A:15%:B:75%), 2&#xa0;min (A:46%:B:54%), 3&#xa0;min (A:100%:B:0%), 1&#xa0;min (A:5%:B:95%).</p>
<p>Following is the instrumental settings: both ion source gas 1 and gas 2 were 50&#xa0;psi, curtain gas (CUR) was 25&#xa0;psi, source temperature was 500&#xb0;C in positive mode while 450&#xb0;C in negative mode, ion spray voltage floating (ISVF) was 5500&#xa0;V in positive mode while 4400&#xa0;V in negative mode, TOF MS scan range was 100&#x2013;1200&#xa0;Da, product ion scan range was 50&#x2013;1000&#xa0;Da, TOF MS scan and product ion scan accumulation time were 0.2 and 0.01&#xa0;s, respectively. Data was acquired in information-dependent acquisition (IDA) with high sensitivity mode, collision energy was 35&#x20;&#xb1; 15&#xa0;eV, and declustering potential was &#xb1;60&#xa0;V (<xref ref-type="sec" rid="s11">Supplementary Table S2</xref>; <xref ref-type="sec" rid="s11">Supplementary Figure&#x20;S1</xref>).</p>
</sec>
<sec id="s2-8-4">
<title>
<italic>Huiyangjiuji</italic> Decoction Solution Preparation</title>
<p>In a bid to prepare HYJJ solution for <italic>in&#x20;vitro</italic> experiments, we established a HIT interaction network with the hub genes and the active components of herbs (<xref ref-type="sec" rid="s11">Supplementary Figure S2</xref>). We selected the shared components of these herbs, included one typical ingredient with the highest degree in each herb: PCW (Hederagenin); AMK(3&#x3b2;-acetoxyatractylone), ACD (Karanjin), CC (Oleic acid), CR (Nobiletin, Naringenin), PCM (Kaempferol, beta-sitosterol), PB (Stigmasterol, Baicalein), SCF (Gomisin R), ZR (Sexangularetin), GF (Quercetin). MTT assay was utilized to ascertain toxicity of the mixture in DLD1 cells (Human colorectal cell line) (<xref ref-type="sec" rid="s11">Supplementary Figure S3</xref>). These selected chemicals were mixed at a concentration of 10&#xa0;ng/ml of each chemical diluted in DMSO (All chemicals have purchased the chemicals in Yuanye Biology, China).</p>
</sec>
<sec id="s2-8-5">
<title>Ribonucleic Acid Sequencing</title>
<p>We treated DLD-1 cells withTNF&#x3b1; (30&#xa0;ng/ml) (Stemcell technology) for 24&#xa0;h and added HYJJ mixture. After 14&#xa0;h, RNA was exacted for the experiment. RNA degradation and contamination was monitored on agarose gels. RNA purity, concentration and integrity were checked using the spectrophotometer, Qubit and the Agilent 2,100, respectively. A total amount of 2&#xa0;&#xb5;g RNA per sample was used as input material for the RNA sample preparations. Sequencing libraries were generated using VAHTS mRNA-seq v2 Library Prep Kit for Illumina following manufacturer&#x2019;s recommendations and index codes were added to attribute sequences to each sample. Briefly, mRNA was purified from total RNA using poly-T oligo-attached magnetic beads. Fragmentation was carried out using fragmentation buffer. First strand cDNA was synthesized and second strand cDNA synthesis was subsequently performed. Remaining overhangs were converted into blunt ends. After adenylation of 3&#x2032; ends of DNA fragments, adaptor with hairpin loop structure were ligated. Then the PCR was performed. At last, Qubit HS quantification, Agilent 2,100 Bioanalyzer/Fragment Analyzer 5,300 quality control, the final library size of about 350 bp. The libraries were sequenced on an Illumina NovaSeq platform to generate 150&#x20;bp paired-end reads, according to the manufacturer&#x2019;s instructions.</p>
<p>Raw data (raw reads) of fastq format were firstly processed through primary quality control. In this step, clean data (clean reads) were obtained by removing read pairs that contain N more than three or the proportion of base with quality value below five is more than 20%, in any end, or adapter sequence was founded. All the downstream analyses were based on the clean data with high quality. Paired-end clean reads were aligned to the reference genome using TopHat. We selected TopHat as the mapping tool for that TopHat can generate a database of splice junctions based on the gene model annotation file and thus a better mapping result than other non-splice mapping tools. Quantification of gene expression level HTSeq was used to count the reads numbers mapped to each gene. Identification of differentially expressed genes Differential expression analysis between two conditions was performed using the DEGSeq R package (1.20.0). Differentially expressed genes were defined as those for which the adjusted <italic>p</italic>-value below 0.05 and the log2 (Fold change) more than 1. Raw data has been submitted to SRA database (PRJNA724825).</p>
</sec>
<sec id="s2-8-6">
<title>Peritoneal Macrophages Isolation</title>
<p>Mice were sacrificed and cold PBS was injected. Peritoneal liquid was collected and centrifuged. The pallet was diluted with RPMI1640 medium.</p>
</sec>
<sec id="s2-8-7">
<title>Intestinal Organoids Culture</title>
<p>MIOs were isolated and cultured according to the protocol (Stemcell technology). Small intestine was washed with cold PBS for 15&#x20;times and digested (Stemcell technology). The supernatant was filtered and centrifugated at 1300&#xa0;rpm for 5&#xa0;min. The pellet was cultured in intestiCult organoid growth medium (Stemcell technology). The medium was exchanged every 2&#xa0;days.</p>
</sec>
<sec id="s2-8-8">
<title>Immunofluorescence</title>
<p>For immunofluorescence, intestinal organoids were incubated with MitoSOX&#x2122; Red Mitochondrial Superoxide Indicator (ThermoFisher) for 10&#xa0;min at 37&#xb0;C. After PBS washing, cells were mounted on the fluorescent scope at 590&#xa0;nm.</p>
</sec>
<sec id="s2-8-9">
<title>Western Blotting</title>
<p>Cells were lyzed and the extracts were centrifuged at 13,000&#xa0;rpm for 20&#xa0;min at 4&#xb0;C. Total protein (40&#xa0;&#xb5;g) was subjected to 8% SDS-PAGE. Proteins were transferred to a nitrocellulose membrane (VWR) and the membranes were then blocked overnight at 4&#xb0;C. Antibody included BAX, BCL-2 and GAPDH antibodies (1:1000) (ThermoFisher). After secondary antibody incubation, protein bands were visualized after anti-rabbit IgG conjugated to horseradish peroxidase treatment.</p>
</sec>
<sec id="s2-8-10">
<title>Scratch Assay</title>
<p>Intestinal epithelial cells-6 (IEC-6) cells were seeded and the monolayer was scratched. The scratched area is photographically monitored at 0 and 24&#xa0;h after treatment. The percentage of the coverage was measured.</p>
</sec>
<sec id="s2-8-11">
<title>Enzyme-Linked Immunosorbent Assay</title>
<p>Mouse IL-2, IL-12, IL-10 as well as Mouse Albumin ELISA Kit were purchased from Abcam. Serum was incubated with antibody cocktail for 1&#xa0;h. After washing for three times, the supernatant was discarded. Streptacidin-HRP solution was added and incubated for 1&#xa0;h. Then TMB solution was added and incubated for 10&#xa0;min. After stop solution was utilized, the plate was mounted and OD was read at 450&#xa0;nm.</p>
</sec>
<sec id="s2-8-12">
<title>Statistics</title>
<p>Data are provided as means&#x20;&#xb1; SEM, n represents the number of independent experiments. All data were tested for significance using Student&#x2019;s unpaired two-tailed t-test and only results with <italic>p</italic>&#x20;&#x3c; 0.05 were considered statistically significant.</p>
</sec>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Huiyangjiuji Decoction Alleviated Ulcerative Colitis Progression</title>
<p>A murine model of ulcerative colitis was established by feeding 4% DSS water to C57 male mice weighing 20&#x2013;25&#xa0;g, six mice in a group with or without HYJJ administration. The severity of experimental colitis was defined according to epithelial deconstruction, shortened colon length, and fecal blood. As shown in <xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>, HE staining showed that HYJJ markedly alleviated the epithelial structural collapse in UC mouse models. Exacerbated fecal album and fecal blood in DSS group were apparently rescued after HYJJ treatment (<xref ref-type="fig" rid="F1">Figures 1B,C</xref>). Consistently, HYJJ therapy successfully maintained the colon length of UC mouse models. Collectively, <italic>in vivo</italic> assay indicated that HYJJ could alleviate UC progression.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>HYJJ alleviates UC progression. <bold>(A)</bold> Representative HE staining images of duodenum and colon sections from C57 mice subject to 4% DSS administration with HYJJ at <bold>5</bold>&#xa0;mg/kg every 2&#xa0;days. Scale bar, 150&#xa0;&#x3bc;m. (B) Albumin level of IBD mice with HYJJ.&#x20;<bold>(C)</bold> Fecal occult blood test of IBD mice with HYJJ.<bold>(D)</bold> Small intestine and colon from control and IBD mice with HYJJ therapy. &#x2a;&#x2a;&#x2a;(<italic>p</italic>&#x20;&#x3c; 0.001) indicate statistically significant difference from saline group, &#x23;&#x23;&#x23;(<italic>p</italic>&#x20;&#x3c; 0.001) indicate statistically significant difference from IBD group.</p>
</caption>
<graphic xlink:href="fphar-12-666432-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>The Herb-Ingredient-Target Network of Huiyangjiuji Decoction</title>
<p>W In a bid to ascertain the pharmacological mechanism of HYJJ, we screened the active components of HYJJ decoction in the TCMSP database and identified 188 active compounds targeting 2,165 genes<italic>.</italic> ACD yields 21 components targeting 92 genes, ZR yields five components targeting 54 genes<italic>,</italic> PCM<italic>.</italic> yields 22 components targeting 256 genes<italic>,</italic> GF yields 92 components targeting 1769 genes, AMK yields seven components targeting 23 genes, CR yields five components targeting 95 genes, SCF yields eight components targeting 30 genes, PCW yields 15 components targeting 30 genes, PB yields 13 components targeting 175 genes, CC yields 10 components targeting 116 genes (<xref ref-type="sec" rid="s11">Supplementary Table&#x20;S1</xref>).</p>
<p>We screened five databases for UC-relevant genes and obtained 5,811 genes after deleting redundant items (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>, <xref ref-type="sec" rid="s11">Supplementary Table S2</xref>). Venn diagram analysis further showed that HYJJ shared 218 putative targets with UC (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>). The overlapping gene symbols were detailed in <xref ref-type="sec" rid="s11">Supplementary Table&#x20;S3</xref>.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The Herb-Ingredient-Target network of HYJJ.&#x20;A Venn analysis showing IBD-related genes from five databases: Drugbank, GeneCard, OMIN, PharmGkb, TTD. <bold>(B)</bold> Venn analysis showing the crosstalk between HYJJ and UC.<bold>(C)</bold> Herbs and compounds as well as all the potential targets were linked.</p>
</caption>
<graphic xlink:href="fphar-12-666432-g002.tif"/>
</fig>
<p>To illustrate the pharmacological mechanism of HYJJ, we constructed a HIT network utilizing Cytoscape (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>). The yellow nodes represent UC genes and the blue nodes represent HYJJ molecules, while colorful dots within the component indicate different herbs, and the edges mean the interaction between UC and components. As illustrated, most herbs not only worked synergistically targeting the same genes, but shared some components, such as GR and ZR, PCM and SCF as well as PB. Furthermore, we explored the role of each herb in UC treatment. The pie chart showed the target genes of each herb in UC (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>), and GO and KEGG analysis was performed with these genes (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>). As the primary source of active components, GF and PCM target genes were similarily enriched in responses to lipopolysaccharide and bacterial as well as metal ions, steroid hormone pathway; CR and PB, as well as ZR influenced responses to oxidative stress and metal ions, while PB specifically regulated adrenergic and catecholamine activity and CR was involved in endocrine resistance; Of note was the anti-neoplastic role of the herbs mentioned above, indicating the potential therapeutic capacity of HYJJ in cancer handling. CR was responsible for responses to fatty acid and acid chemicals as well as the regulation of Adenosine 5&#x2018;-monophosphate (AMP)-activated protein kinase (AMPK) and peroxisome proliferators-activated receptors (PPAR) signaling pathways that exert an anti-inflammatory role in UC (<xref ref-type="bibr" rid="B3">Arafa et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B51">Xu et&#x20;al., 2017</xref>). Other seemingly minor but vital herbs were ACD, SCF, PSW and AMK. Interestingly, ACD, AMK as well as PSW associated with muscle contraction and vasoconstriction, while AMK and PSW as well as SCF not only worked with neurological processes, including neuroactive ligand-receptor interaction and neurotransmitter receptor activity, but improved digestion processes, such as protein digestion and absorption, and salivary secretion. From the enrichment analysis angle, HYJJ decoction could suppress inflammation, orchestrate hormone activity and restore gut function, thereby holistically combating&#x20;UC.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>The function of each herb in the pathogenesis of UC. <bold>(A)</bold> Pie chart illustrating the target genes of each herb in UC.<bold>(B)</bold> GO and KEGG analysis showing the enrichment of herb-target&#x20;genes.</p>
</caption>
<graphic xlink:href="fphar-12-666432-g003.tif"/>
</fig>
<p>We construct a full PPI network with a PPI enrichment <italic>p</italic>-value (&#x3c;1.0&#xa0;e-16) based on the STRING database (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>) and extracted 29&#x20;hub-genes (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>). The median values of BC, CC, DC, EC, LAC, and NC in the left subnetwork were 76.52928591, 0.4048583, 10, 0.030461067, 5.333333333, and 6.5, respectively. The median values in the right subnetwork (hub genes) were 15.67041167, 0.591562335, 19.5, 0.1026759405, 11.64171123, 13.451165665, respectively. 29 hub genes with higher than the median values of the features were identified (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>). In line with the individual function of each herb, KEGG analysis demonstrated that the hub-genes in the HIT network were enriched in infection, cancer and endocrine processes.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>PPI network and hub genes. <bold>(A)</bold> PPI interaction network established by the target genes of HYJJ in UC. <bold>(B)</bold> Hub genes of PPI interaction network.<bold>(C)</bold> KEGG analysis of the hub&#x20;genes.</p>
</caption>
<graphic xlink:href="fphar-12-666432-g004.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Expression Profile of Human Colorectal Cancer Cells With Huiyangjiuji Decoction Treatment</title>
<p>Network pharmacological analysis not only indicated the anti-inflammatory effect of HYJJ, but also pointed out the anti-neoplastic potential of this decoction. Given that UC has been regarded as an independent risk factor of UC-CRC, we treated DLD-1 cells with HYJJ and extracted RNA for RNA-sequencing. As a result, 784 DEGs were obtained between HYJJ group and the control group. Among these DEGs, 643 genes were down-regulated and 141 were up-regulated (<xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>). Based on the STRING database, PPI network composed of down-regulated or up-regulated genes were constructed (Figure B, and C). We then performed GO and pathway enrichment analysis. The top enrichments of up-regulated genes in CC were membrane part, intrinsic component as well as integral component of membrane; In BP were regulation of cell response to heat and xenobiotic stimulus; In MF were molecular function regulator and enzyme regulator activity. Of note, the top enrichment of down-regulated genes in CC was cell periphery, plasma membrane and extracellular region, in BP were response to stimulus, regulation of multicellular organismal process as well as inflammatory response, in MF were receptor binding and cytokine activity (<xref ref-type="fig" rid="F5">Figure&#x20;5E</xref>). KEGG analysis showed that HYJJ treatment facilitated cell adhesion molecules, salivary and pancreatic secretion, glutamatergic and dopaminergic synapse, fat digestion and absorption, all of which were mentioned in network analysis about the individual role of AMK and PSW as well as SCF, these seemingly minor components of HYJJ.&#x20;Not surprisingly, HYJJ down-regulated genes were enriched in inflammation-related pathways, such as cytokine-cytokine receptor interaction, TNF signaling pathway as well as IBD, NOD-like and Toll-like receptor signaling pathways (<xref ref-type="fig" rid="F5">Figure&#x20;5F</xref>), fully corroborating the anti-inflammatory as well as the anti-cancer therapeutic role of&#x20;HYJJ.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Gene Ontology (GO) and KEGG enrichment analysis of the targets. <bold>(A)</bold> Chart illustrating the DEGs between control and HYJJ-treated DLD-1 cells. <bold>(B&#x2013;C)</bold> PPI interaction network established by up-regulated genes or down-regulated genes. <bold>(D)</bold> GO analysis of up-regulated genes of HYJJ treated DLD-1 cells. <bold>(E)</bold> GO analysis of Down-regulated genes of HYJJ treated DLD-1 cells. <bold>(F)</bold> KEGG analysis of DEGs of HYJJ treated DLD-1 cells.</p>
</caption>
<graphic xlink:href="fphar-12-666432-g005.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Huiyangjiuji Decoction Rescued TNF&#x3b1;-Hampered TNF&#x3b1;-Hampered Intestinal Stem Cells Survival</title>
<p>Intestinal organoids (IOs) culture is an ideal tool to mimic the stem cell niche and investigate the stemness of ISCs under pathological settings. The <italic>ex-vivo</italic> IBD cellular model was established by treating IOs with TNF&#x3b1; (20&#xa0;ng/ml, 24&#xa0;h), and then HYJJ was administered for another 24&#xa0;h. TNF is interconnected with ROS, dysregulation of which is a hallmark of cancers and inflammatory diseases (<xref ref-type="bibr" rid="B6">Blaser et&#x20;al., 2016</xref>). Given the inhibition of TNF signaling pathway by HYJJ shown in RNA-seq results, and that excessive reactive oxygen species (ROS) enables stem cells to escape from a long-lived quiescent state-a slow-cycling state and enter into a proliferative state undergoing differentiation or apoptosis (<xref ref-type="bibr" rid="B43">Tothova et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B59">Zhang et&#x20;al., 2018</xref>), we examined ROS level as well as apoptosis of IOs. As illustrated in <xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>, TNF&#x3b1; increased ROS level, an effect that was reversed by HYJJ.&#x20;The swollen shape and dark lumen of IOs in the TNF&#x3b1; group were also rescued by HYJJ administration (30&#xa0;ng/ml, 24&#xa0;h). Moreover, the number of multi-buds IOs was considerably decreased after TNF&#x3b1; treatment, which was successfully reversed by HYJJ (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>). Western blotting results showed the increased apoptosis in the presence of TNF&#x3b1; was suppressed by HYJJ, as evidence by the protein expression of BAC and BCL-2 (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>). Altogether, HYJJ facilitates the re-establishment of the ISCs niche in an <italic>ex-vivo</italic> model of ulcerative colitis.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>HYJJ rescued TNF&#x3b1;-hampered IOs functions.<bold>(A)</bold> Immunofluorescent staining illustrating the mitochondrial stress of TNF&#x3b1;-treated (20&#xa0;ng/ml, 24&#xa0;h) IOs in the presence of HYJJ (30&#xa0;ng/ml, 24&#xa0;h). <bold>(B)</bold> Bar charts (<italic>n</italic>&#x20;&#x3d; 5) illustrating the number of multi-buds IOs in the presence of HYJJ and TNF&#x3b1;. <bold>(C)</bold> Original western blot pictures and bar charts (<italic>n</italic>&#x20;&#x3d; 5) illustrating the protein expression of Bcl-2 and BAX in <italic>&#x3b1;</italic>-treated IOs with HYJJ.&#x20;&#x2a;&#x2a;&#x2a;(<italic>p</italic>&#x20;&#x3c; 0.001) indicate statistically significant difference from saline group, &#x23;&#x23;&#x23;(<italic>p</italic>&#x20;&#x3c; 0.001) indicate statistically significant difference from UC&#x20;group.</p>
</caption>
<graphic xlink:href="fphar-12-666432-g006.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Huiyangjiuji Decoction Suppressed Inflammation and Contributed to Mucosal Healing</title>
<p>M&#x3c6;s, antigen-presenting cells with high plasticity linking the innate and adaptive immune system, transit to the pro-inflammatory phenotype (M1 M&#x3c6;s) and secret interleukins to amplify the inflammation processes, such as IL-2 and IL-12, as well as IL-10. Nevertheless, M&#x3c6;s facilitate wound-healing when they act as guardians of the homeostasis and present M2 phenotype.</p>
<p>ELISA confirmed that HYJJ administration inhibited the levels of IL-2, IL-10 as well as IL-12 in the serum collected from mice undergoing experimental colitis (<xref ref-type="fig" rid="F7">Figure&#x20;7A</xref>). Moreover, We established a co-culture system by M&#x3c6;s and IEC-6 cells to mimic the inflammatory microenvironment around epithelial cells. Firstly, we isolated peritoneal M&#x3c6;s from HYJJ-DSS mice and co-cultured these M&#x3c6;s with IEC-6 cells for 24&#xa0;h. A scratch assay showed that M&#x3c6;s from DSS mice hampered the migration capacity of IEC-6 cells, but no detrimental role of HYJJ-DSS M&#x3c6;s was observed (<xref ref-type="fig" rid="F7">Figure&#x20;7B</xref>). Altogether, HYJJ might inhibit M1 M&#x3c6;s transition and hence suppressing the pro-inflammatory interleukins levels in DSS-induced colitis&#x20;mice.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>The roles of HYJJ in the inflammatory status.<bold>(A)</bold> Bar charts (<italic>n</italic>&#x20;&#x3d; 5) illustrating the levels of IL-2, IL-10 and IL-12 of UC mice with HYJJ treatment.<bold>(B)</bold> Scratch assay showing the migration capacity of IEC-6 cells co-cultured with macrophages from UC mice with HYJJ treatment. &#x2a;&#x2a;&#x2a;(<italic>p</italic>&#x20;&#x3c; 0.001) indicate statistically significant difference from saline group, &#x23;&#x23;&#x23;(<italic>p</italic>&#x20;&#x3c; 0.001) indicate statistically significant difference from UC&#x20;group.</p>
</caption>
<graphic xlink:href="fphar-12-666432-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Large-scale functional genomics findings in various disease models have proposed that single-gene knockouts convey minimal information on phenotype. Only 19% of genes are crucial across model organisms, and most single-gene manipulations are likely to be involved in the prevalence rate under pathological stimuli (<xref ref-type="bibr" rid="B21">Hopkins, 2008</xref>). Therefore, the philosophy &#x201c;one gene, one drug, one disease&#x201d; of drug design has been challenged over the decades. Emerging network pharmacology has shed light on TCM and offered a practical approach to elucidate the pharmacological mechanisms of numerous compounds. Toxicity and efficacy account for the major sources of attrition in TCM therapy and have always aroused general concerns. In particular, inadequate animal <italic>in-vivo</italic> animal experiments and unknown pharmacological mechanisms lie at the heart of the&#x20;query.</p>
<p>HYJJ decoction encompasses ten herbs, and the combination of ACD, ZR and GF has been introduced as Si-Ni decoction carrying on a potential anti-inflammatory effect on the treatment of septic and shock sepsis (<xref ref-type="bibr" rid="B11">Chen et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B8">Brislinger et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B57">Zeng et&#x20;al., 2019</xref>). However, the therapeutic role of HYJJ in UC has not yet been elucidated. UC is the subtype of IBD and leads to digestive disorders, inflammation and even UC-CRC. In the present study, our <italic>in vivo</italic> findings showed that HYJJ effectively alleviated the progression of experimental colitis, and explored the pharmacological mechanism utilizing network pharmacology analysis. By integrating UC-associated genes from five databases and obtaining the active components of HYJJ in the TCMSP database, 218 target genes were identified. &#x39a;&#x395;GG analysis demonstrated the enrichment of hub genes in cancer as well as infection pathways, which corroborated the anti-inflammatory role of HYJJ.&#x20;In the formula, combating inflammation was the principal target accomplished by eight herbs, such as ACD, ZR, GF, PGM (<xref ref-type="bibr" rid="B24">Jin et&#x20;al., 2020</xref>), PB (<xref ref-type="bibr" rid="B42">Tian et&#x20;al., 2020</xref>), SCF (<xref ref-type="bibr" rid="B27">Li et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B28">Li et&#x20;al., 2021</xref>), PCW (<xref ref-type="bibr" rid="B58">Zhang et&#x20;al., 2018</xref>) as well as CC (<xref ref-type="bibr" rid="B13">Csikos et&#x20;al., 2020</xref>). In addition to inflammation, the recovery of gut motility and orchestration of the gut innervation were also underlined. On the one hand, adrenergic (<xref ref-type="bibr" rid="B31">Nezi et&#x20;al., 2000</xref>; <xref ref-type="bibr" rid="B17">Furlan et&#x20;al., 2006</xref>) and cholinergic (<xref ref-type="bibr" rid="B30">Mogilevski et&#x20;al., 2019</xref>) systems work synergistically to maintain the homeostasis of the gastrointestinal tract, and our KEGG analysis demonstrated the regulatory role of PB in adrenergic and catecholamine activity, and CR in endocrine resistance. On the other hand, given the dysmotility caused by the inflammatory mediators and neural circuitry during UC progression, HYJJ included ACD, AMK, and PSW to improve the contraction of gut muscles. Consistently, HYJJ decoction took the brain-gut axis into consideration (<xref ref-type="bibr" rid="B41">Teratani et&#x20;al., 2020</xref>) and selected compounds able to influence neurotransmitter activity. GO and KEGG analysis showed that AMK, PSW and SCF target genes were not only enriched in neurological pathways, including neuroactive ligand-receptor interaction and neurotransmitter receptor activities, but also contributed to digestive functions, such as protein digestion and absorption, as well as salivary secretion. Many of these effects were seemingly rather indirectly combating secretory diarrhea frequently occurring during IBD (<xref ref-type="bibr" rid="B36">Schiller, 1999</xref>), than directly interacting with the progression of IBD (<xref ref-type="bibr" rid="B25">Jonge et&#x20;al., 2020</xref>). Additionally, given the high fiber in the components of HYJJ decoction and the improved gut health following ingestion of plant-based constituents (<xref ref-type="bibr" rid="B9">Carvalhana et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B1">Alferink et&#x20;al., 2020</xref>), the intrinsic nature of these herb compounds was also beneficial for the gut recovery. Collectively, network pharmacological analysis demonstrated that HYJJ provided a potential therapeutic strategy for UC handling by suppressing inflammation, restoring the homeostasis of hormones and innervation, and facilitating gut motility and digestion.</p>
<p>In a bid to corroborate the findings above, DLD-1 cells were treated with the critical components of HYJJ and performed RNA-sequencing. In line with the results of network pharmacological analysis, HYJJ down-regulated UC-related inflammatory pathways, such as IBD and TNF, NOD-like and Toll-like receptor signaling pathways, and facilitated salivary and pancreatic secretion, glutamatergic and dopaminergic synapse, fat digestion and absorption, all of which were mentioned in network analysis about the individual roles of HYJJ.&#x20;Most interestingly, the inevitable concerns about the toxicity of HYJJ were also clearly addressed. First, the primary active components in the decoction were acid chemicals, especially GF, and might hamper the mucosa, and CR could counteract and neutralize the acid irritation (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>). Secondly, the detrimental role of ACD for gestation has been proposed in Ben Cao Gang Mu, the most complete medical monograph written in the history of traditional Chinese medicine by LI Shi-Zhen, and KEGG analysis also confirmed the association of ACD and SCF with the maternal process involved in female pregnancy. Given the reported protective role of SCF in pregnancy (<xref ref-type="bibr" rid="B32">Panossian and Wikman, 2008</xref>), we proposed that the toxicity of ACD might be neutralized by SCF, which needs further experimental validations <italic>in vivo</italic> and <italic>in&#x20;vitro</italic>.</p>
<p>Our <italic>ex-vivo</italic> experiments further demonstrated the positive role of HYJJ for mucosal healing and anti-inflammation. IO is a primary culture of intestinal stem cells and represents the dynamic progression of mucosal recovery, providing a specific powerful tool to mimic the interplay between intestinal stem cells and immune cells and mostly suitable for investigating IBD (<xref ref-type="bibr" rid="B55">Yin et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B14">Deuring et&#x20;al., 2019</xref>). Stem cells are in a quiescent state to maintain a long-lived capacity in non-inflammatory settings, and enter into a proliferative state upon stimulations including excessive ROS, thereby undergoing apoptosis (<xref ref-type="bibr" rid="B43">Tothova et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B59">Zhang et&#x20;al., 2018</xref>). We found the exacerbated ROS and apoptosis of IOs could be rescued after HYJJ treatment, which suggested that HYJJ was beneficial for re-epithelization. Furthermore, the phenotypes of M&#x3c6;s reflect the immune status inside the body and exert distinct functions. In the case of inflammation, M1 M&#x3c6;s secret pro-interleukins and amplify immune responses by antigen-presenting capacity. However, M2 M&#x3c6;s act as safe guardians for homeostasis and wound-healing. We therefore isolated peritoneal M&#x3c6;s from HYJJ-UC mice and co-cultured with IEC-6 cells, aiming to mimic the immunological environment of the ISCs niche. As a result, HYJJ treatment decreased the levels of pro-inflammatory interleukins in the serum of UC mice, and M&#x3c6;s from HYJJ-treated mice did not compromise the migration of IECs, pointing out the anti-inflammatory role of HYJJ in&#x20;UC.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>By using a computational systems pharmacology approach and experimental evidence, we concluded that HYJJ alleviates experimental colitis progression by improving epithelial reconstitution and inhibiting pro-inflammatory response.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref> data as well as in SRA database (PRJNA724825).</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by animal care and use committee of jining medical university.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>Study concept and design: JY. Data acquisition: JY, BZ. Data analysis and interpretation: WY, HC. Drafting of the manuscript; JY. Critical revision of the manuscript for important intellectual content: JY and WY. Statistical analysis: WY, BZ. Obtained funding:&#x20;JY.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This study was supported by the National Natural Science Foundation of China (Grant No. 31801172).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2021.666432/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2021.666432/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table2.XLSX" id="SM1" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image3.JPEG" id="SM2" mimetype="application/JPEG" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table3.XLSX" id="SM3" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.JPEG" id="SM4" mimetype="application/JPEG" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image2.JPEG" id="SM5" mimetype="application/JPEG" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table4.XLSX" id="SM6" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table1.XLSX" id="SM7" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="DataSheet1.XLSX" id="SM8" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<sec id="s12">
<title>Abbreviations</title>
<p>IBD, Inflammatory bowel disease; IOs, intestinal organoids; M&#x3c6;s, Macrophages; HYJJ, <italic>Huiyangjiuji</italic> decoction; ISCs, intestinal stem cells; TCM, Traditional Chinese Medicine; PPIs, Protein-protein interactions; MOS, mitochondrial stress; UC, Ulcerative colitis.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alferink</surname>
<given-names>L. J.&#x20;M.</given-names>
</name>
<name>
<surname>Erler</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>de Knegt</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>H. L. A.</given-names>
</name>
<name>
<surname>Metselaar</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Darwish Murad</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Adherence to a Plant-Based, High-Fibre Dietary Pattern Is Related to Regression of Non-alcoholic Fatty Liver Disease in an Elderly Population</article-title>. <source>Eur. J.&#x20;Epidemiol.</source> <volume>35</volume>, <fpage>1069</fpage>&#x2013;<lpage>1085</lpage>. <pub-id pub-id-type="doi">10.1007/s10654-020-00627-2</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aly</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Al-Alousi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Salem</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Licorice: a Possible Anti-inflammatory and Anti-ulcer Drug</article-title>. <source>AAPS PharmSciTech</source> <volume>6</volume>, <fpage>E74</fpage>&#x2013;<lpage>E82</lpage>. <pub-id pub-id-type="doi">10.1208/pt060113</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arafa</surname>
<given-names>E.-S. A.</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>W. R.</given-names>
</name>
<name>
<surname>Zaher</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Omar</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Gliclazide Attenuates Acetic Acid-Induced Colitis via the Modulation of PPAR&#x3b3;, NF-&#x39a;b and MAPK Signaling Pathways</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>391</volume>, <fpage>114919</fpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2020.114919</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashburner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Botstein</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cherry</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Gene Ontology: Tool for the Unification of Biology</article-title>. <source>Nat. Genet.</source> <volume>25</volume>, <fpage>25</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/75556</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Metabolomics Study of Different Parts of Licorice from Different Geographical Origins and Their Anti&#x2010;inflammatory Activities</article-title>. <source>J.&#x20;Sep. Sci.</source> <volume>43</volume>, <fpage>1593</fpage>&#x2013;<lpage>1602</lpage>. <pub-id pub-id-type="doi">10.1002/jssc.201901013</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blaser</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dostert</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mak</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>TNF and ROS Crosstalk in Inflammation</article-title>. <source>Trends Cel Biol.</source> <volume>26</volume>, <fpage>249</fpage>&#x2013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2015.12.002</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Borren</surname>
<given-names>N. Z.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Sandler</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Ananthakrishnan</surname>
<given-names>A. N.</given-names>
</name>
</person-group> (<year>2020</year>). <publisher-name>Inflamm Bowel Dis</publisher-name>. <pub-id pub-id-type="doi">10.1093/ibd/izaa338</pub-id> <article-title>Longitudinal Trajectory of Fatigue in Patients with Inflammatory Bowel Disease: A Prospective Study</article-title>. <source>Inflamm. Bowel Dis.</source>. <pub-id pub-id-type="doi">10.1093/ibd/izaa338</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brislinger</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Daxb&#xf6;ck</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rossmanith</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>St&#xfc;ckler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Falkenhagen</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Bai Hu Tang, Si Ni Tang, and Xue Bi Tang Amplify Pro-inflammatory Activities and Reduce Apoptosis in Endothelial Cells in a Cell Culture Model of Sepsis</article-title>. <source>J.&#x20;Ethnopharmacology</source> <volume>225</volume>, <fpage>309</fpage>&#x2013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2018.07.021</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalhana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Cortez-Pinto</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Improving Dietary Patterns in Patients with Nonalcoholic Fatty Liver Disease</article-title>. <source>Curr. Opin. Clin. Nutr. Metab. Care</source> <volume>15</volume>, <fpage>468</fpage>&#x2013;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1097/mco.0b013e3283566614</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F. P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Jong</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Modern Use of Chinese Herbal Formulae from Shang-Han Lun</article-title>. <source>Chin. Med. J.&#x20;(Engl)</source> <volume>122</volume>, <fpage>1889</fpage>&#x2013;<lpage>1894</lpage>. </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.-C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.-C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>K.-H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>L.-C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>T.-C.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Simultaneous Use of Traditional Chinese Medicine (Si-ni-tang) to Treat Septic Shock Patients: Study Protocol for a Randomized Controlled Trial</article-title>. <source>Trials</source> <volume>12</volume>, <fpage>199</fpage>. <pub-id pub-id-type="doi">10.1186/1745-6215-12-199</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Beneficial Regulatory Effects of Polymethoxyflavone-Rich Fraction from Ougan (Citrus Reticulata Cv. Suavissima) Fruit on Gut Microbiota and Identification of its Intestinal Metabolites in Mice</article-title>. <source>Antioxidants (Basel)</source> <volume>9</volume>. <pub-id pub-id-type="doi">10.3390/antiox9090831</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Csikos</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cseko</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ashraf</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Kemeny</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kereskai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kocsis</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Effects of Thymus Vulgaris L., Cinnamomum Verum J.Presl and Cymbopogon Nardus (L.) Rendle Essential Oils in the Endotoxin-Induced Acute Airway Inflammation Mouse Model</article-title>. <source>Molecules</source> <volume>25</volume>. <pub-id pub-id-type="doi">10.3390/molecules25153553</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deuring</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>de Haar</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Pregnane X Receptor Activation Constrains Mucosal NF-&#x39a;b Activity in Active Inflammatory Bowel Disease</article-title>. <source>PLoS One</source> <volume>14</volume>, <fpage>e0221924</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0221924</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Endo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mihara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Oikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Odaguchi</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Zingiberis Siccatum Rhizoma, the Active Component of the Kampo Formula Daikenchuto, Induces Anti-inflammatory Actions through Alpha7 Nicotinic Acetylcholine Receptor Activation</article-title>. <source>Neurogastroenterol Motil.</source> <volume>29</volume>. <pub-id pub-id-type="doi">10.1111/nmo.13139</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Endo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Oikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Odaguchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hanawa</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Possible Anti-inflammatory Role of Zingiberis Processum Rhizoma, One Component of the Kampo Formula Daikenchuto, against Neutrophil Infiltration through Muscarinic Acetylcholine Receptor Activation</article-title>. <source>J.&#x20;Pharmacol. Sci.</source> <volume>137</volume>, <fpage>379</fpage>&#x2013;<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1016/j.jphs.2018.08.001</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furlan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ardizzone</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Palazzolo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rimoldi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perego</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Barbic</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Sympathetic Overactivity in Active Ulcerative Colitis: Effects of Clonidine</article-title>. <source>Am. J.&#x20;Physiology-Regulatory, Integr. Comp. Physiol.</source> <volume>290</volume>, <fpage>R224</fpage>&#x2013;<lpage>R232</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.00442.2005</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamosh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>A. F.</given-names>
</name>
<name>
<surname>Amberger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bocchini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Valle</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>McKusick</surname>
<given-names>V. A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Online Mendelian Inheritance in Man (OMIM), a Knowledgebase of Human Genes and Genetic Disorders</article-title>. <source>Nucleic Acids Res.</source> <volume>30</volume>, <fpage>52</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1093/nar/30.1.52</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herath</surname>
<given-names>K. H. I. N. M.</given-names>
</name>
<name>
<surname>Bing</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>G.-O.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.-C.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Citrus Hallabong [(Citrus Unshiu &#xd7; <italic>C. sinensis</italic>) &#xd7; <italic>C. reticulata</italic>)] Exerts Potent Anti-inflammatory Properties in Murine Splenocytes and TPA-Induced Murine Ear Oedema Model</article-title>. <source>Pharm. Biol.</source> <volume>54</volume>, <fpage>2939</fpage>&#x2013;<lpage>2950</lpage>. <pub-id pub-id-type="doi">10.1080/13880209.2016.1194865</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.-C.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Investigation of Heat Treating Conditions for Enhancing the Anti-inflammatory Activity of Citrus Fruit (Citrus Reticulata) Peels</article-title>. <source>J.&#x20;Agric. Food Chem.</source> <volume>56</volume>, <fpage>7976</fpage>&#x2013;<lpage>7982</lpage>. <pub-id pub-id-type="doi">10.1021/jf801434c</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hopkins</surname>
<given-names>A. L.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Network Pharmacology: the Next Paradigm in Drug Discovery</article-title>. <source>Nat. Chem. Biol.</source> <volume>4</volume>, <fpage>682</fpage>&#x2013;<lpage>690</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.118</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jazayeri</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Daghighi</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Rezaee</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Lifestyle Alters GUT-Bacteria Function: Linking Immune Response and Host</article-title>. <source>Best Pract. Res. Clin. Gastroenterol.</source> <volume>31</volume>, <fpage>625</fpage>&#x2013;<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpg.2017.09.009</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jess</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Loftus</surname>
<given-names>E. V.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Velayos</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Harmsen</surname>
<given-names>W. S.</given-names>
</name>
<name>
<surname>Zinsmeister</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Smyrk</surname>
<given-names>T. C.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Risk of Intestinal Cancer in Inflammatory Bowel Disease: a Population-Based Study from Olmsted County, Minnesota</article-title>. <source>Gastroenterology</source> <volume>130</volume>, <fpage>1039</fpage>&#x2013;<lpage>1046</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2005.12.037</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>T.-Y.</given-names>
</name>
<name>
<surname>Rong</surname>
<given-names>P.-Q.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>H.-Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.-P.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>G.-Q.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Clinical and Preclinical Systematic Review of Panax Ginseng C. A. Mey and its Compounds for Fatigue</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>1031</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.01031</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jonge</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Ardelean</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Bijvelds</surname>
<given-names>M. J.&#x20;C.</given-names>
</name>
<name>
<surname>Vergani</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Strategies for Cystic Fibrosis Transmembrane Conductance Regulator Inhibition: from Molecular Mechanisms to Treatment for Secretory Diarrhoeas</article-title>. <source>FEBS Lett.</source> <volume>594</volume>, <fpage>4085</fpage>&#x2013;<lpage>4108</lpage>. <pub-id pub-id-type="doi">10.1002/1873-3468.13971</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanehisa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>KEGG: Kyoto Encyclopedia of Genes and Genomes</article-title>. <source>Nucleic Acids Res.</source> <volume>28</volume>, <fpage>27</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Network Pharmacology Based Investigation into the Bioactive Compounds and Molecular Mechanisms of Schisandrae Chinensis Fructus against Drug-Induced Liver Injury</article-title>. <source>Bioorg. Chem.</source> <volume>96</volume>, <fpage>103553</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2019.103553</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>A Network Pharmacology-Integrated Metabolomics Strategy for Clarifying the Action Mechanisms of Schisandrae Chinensis Fructus for Treating Drug-Induced Liver Injury by Acetaminophen</article-title>. <source>Bioorg. Med. Chem.</source> <volume>31</volume>, <fpage>115992</fpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2020.115992</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merlos-Su&#xe1;rez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barriga</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Iglesias</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>C&#xe9;spedes</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Rossell</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse</article-title>. <source>Cell Stem Cell</source> <volume>8</volume>, <fpage>511</fpage>&#x2013;<lpage>524</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2011.02.020</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mogilevski</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Burgell</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>P. R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Review Article: the Role of the Autonomic Nervous System in the Pathogenesis and Therapy of IBD</article-title>. <source>Aliment. Pharmacol. Ther.</source> <volume>50</volume>, <fpage>720</fpage>&#x2013;<lpage>737</lpage>. <pub-id pub-id-type="doi">10.1111/apt.15433</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Nezi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mastorakos</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mouslech</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2000</year>). &#x201c;<article-title>Corticotropin Releasing Hormone and the Immune/Inflammatory Response</article-title>,&#x201d; in <source>Endotext, MDText.Com, Inc. Copyright &#xa9; 2000-2021</source>. Editors <person-group person-group-type="editor">
<name>
<surname>Feingold</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Anawalt</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Boyce</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chrousos</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>de Herder</surname>
<given-names>W. W.</given-names>
</name>
<etal/>
</person-group> (<publisher-loc>South Dartmouth (MA)</publisher-loc>: <publisher-name>MDText.com, Inc.</publisher-name>). </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panossian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wikman</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Pharmacology of Schisandra Chinensis Bail.: an Overview of Russian Research and Uses in Medicine</article-title>. <source>J.&#x20;Ethnopharmacology</source> <volume>118</volume>, <fpage>183</fpage>&#x2013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2008.04.020</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rebhan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chalifa-Caspi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Prilusky</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lancet</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>GeneCards: Integrating Information about Genes, Proteins and Diseases</article-title>. <source>Trends Genet.</source> <volume>13</volume>, <fpage>163</fpage>. <pub-id pub-id-type="doi">10.1016/s0168-9525(97)01103-7</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ru</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>TCMSP: a Database of Systems Pharmacology for Drug Discovery from Herbal Medicines</article-title>. <source>J.&#x20;Cheminform</source> <volume>6</volume>, <fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/1758-2946-6-13</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Safran</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dalah</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Iny Stein</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shmoish</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>GeneCards Version 3: the Human Gene Integrator</article-title>. <source>Database</source> <volume>2010</volume>, <fpage>baq020</fpage>. <pub-id pub-id-type="doi">10.1093/database/baq020</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schiller</surname>
<given-names>L. R.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Secretory Diarrhea</article-title>. <source>Curr. Gastroenterol. Rep.</source> <volume>1</volume>, <fpage>389</fpage>&#x2013;<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1007/s11894-999-0020-8</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Demchak</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>G. D.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Biological Network Exploration with Cytoscape 3</article-title>. <source>Curr. Protoc. Bioinformatics</source> <volume>47</volume> (<issue>13</issue>), <fpage>8</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/0471250953.bi0813s47</pub-id>1&#x20;</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Murano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nakata</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Single Cell Analysis of Crohn&#x27;s Disease Patient-Derived Small Intestinal Organoids Reveals Disease Activity-dependent Modification of Stem Cell Properties</article-title>. <source>J.&#x20;Gastroenterol.</source> <volume>53</volume>, <fpage>1035</fpage>&#x2013;<lpage>1047</lpage>. <pub-id pub-id-type="doi">10.1007/s00535-018-1437-3</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szklarczyk</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gable</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Lyon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Junge</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wyder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huerta-Cepas</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>STRING V11: Protein-Protein Association Networks with Increased Coverage, Supporting Functional Discovery in Genome-wide Experimental Datasets</article-title>. <source>Nucleic Acids Res.</source> <volume>47</volume>, <fpage>D607</fpage>&#x2013;<lpage>D613</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F.-X.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>CytoNCA: a Cytoscape Plugin for Centrality Analysis and Evaluation of Protein Interaction Networks</article-title>. <source>Biosystems</source> <volume>127</volume>, <fpage>67</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.biosystems.2014.11.005</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teratani</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mikami</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nakamoto</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Okabayashi</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>The Liver-Brain-Gut Neural Arc Maintains the Treg Cell Niche in the Gut</article-title>. <source>Nature</source> <volume>585</volume>, <fpage>591</fpage>&#x2013;<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2425-3</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>W.-T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.-W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.-P.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.-R.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Structural Characterization of an Acid Polysaccharide from Pinellia Ternata and its Induction Effect on Apoptosis of Hep G2 Cells</article-title>. <source>Int. J.&#x20;Biol. Macromolecules</source> <volume>153</volume>, <fpage>451</fpage>&#x2013;<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.02.219</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tothova</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kollipara</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Huntly</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Castrillon</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Cullen</surname>
<given-names>D. E.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress</article-title>. <source>Cell</source> <volume>128</volume>, <fpage>325</fpage>&#x2013;<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.01.003</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Giessen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Binyamin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Belogolovski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Frishman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tenenbaum-Gavish</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hadar</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Modulation of Cytokine Patterns and Microbiome during Pregnancy in IBD</article-title>. <source>Gut</source> <volume>69</volume>, <fpage>473</fpage>&#x2013;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2019-318263</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veauthier</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hornecker</surname>
<given-names>J.&#x20;R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Crohn&#x27;s Disease: Diagnosis and Management</article-title>. <source>Am. Fam. Physician</source> <volume>98</volume>, <fpage>661</fpage>&#x2013;<lpage>669</lpage>. </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voskuil</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Spekhorst</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>van der Sloot</surname>
<given-names>K. W. J.</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Dijkstra</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>van der Woude</surname>
<given-names>C. J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease Phenotypes</article-title>. <source>J.&#x20;Crohns Colitis</source>. <volume>6</volume>, <fpage>jjaa223</fpage>. <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjaa223</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Therapeutic Target Database 2020: Enriched Resource for Facilitating Research and Early Development of Targeted Therapeutics</article-title>. <source>Nucleic Acids Res.</source> <volume>48</volume>, <fpage>D1031</fpage>&#x2013;<lpage>d1041</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz981</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whirl-Carrillo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McDonagh</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Hebert</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sangkuhl</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Thorn</surname>
<given-names>C. F.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Pharmacogenomics Knowledge for Personalized Medicine</article-title>. <source>Clin. Pharmacol. Ther.</source> <volume>92</volume>, <fpage>414</fpage>&#x2013;<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1038/clpt.2012.96</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wishart</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Feunang</surname>
<given-names>Y. D.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Marcu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>DrugBank 5.0: a Major Update to the DrugBank Database for 2018</article-title>. <source>Nucleic Acids Res.</source> <volume>46</volume>, <fpage>D1074</fpage>&#x2013;<lpage>d1082</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Polysaccharide of Atractylodes Macrocephala Koidz (PAMK) Alleviates Cyclophosphamide-Induced Immunosuppression in Mice by Upregulating CD28/IP3R/PLCgamma-1/AP-1/NFAT Signal Pathway</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>529657</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.529657</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Madecassic Acid, the Contributor to the Anti-colitis Effect of Madecassoside, Enhances the Shift of Th17 toward Treg Cells via the PPAR&#x3b3;/AMPK/ACC1 Pathway</article-title>. <source>Cell Death Dis</source> <volume>8</volume>, <fpage>e2723</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2017.150</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>An Overview of Molecular Profiles in Ulcerative Colitis-Related Cancer</article-title>. <source>Inflamm. Bowel Dis.</source> <volume>24</volume>, <fpage>1883</fpage>&#x2013;<lpage>1894</lpage>. <pub-id pub-id-type="doi">10.1093/ibd/izy221</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B.-C.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.-S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Anti-inflammatory Activity of Licorice, a Widely Used Chinese Herb</article-title>. <source>Pharm. Biol.</source> <volume>55</volume>, <fpage>5</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1080/13880209.2016.1225775</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Atractylodes Macrocephala Koidz. For the Treatment of Chronic Gastritis</article-title>. <source>Front. Pharmacol.</source> <volume>10</volume>, <fpage>1629</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2019.01629</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hakim</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>6-Thioguanine Inhibits Rotavirus Replication through Suppression of Rac1 GDP/GTP Cycling</article-title>. <source>Antiviral Res.</source> <volume>156</volume>, <fpage>92</fpage>&#x2013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.06.011</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>ACE2 Contributes to the Maintenance of Mouse Epithelial Barrier Function</article-title>. <source>Biochem. Biophysical Res. Commun.</source> <volume>533</volume>, <fpage>1276</fpage>&#x2013;<lpage>1282</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2020.10.002</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mai</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Si-ni-tang (A Chinese Herbal Formula) for Improving Immunofunction in Sepsis: Study Protocol for a Pilot Randomized Controlled Trial</article-title>. <source>Trials</source> <volume>20</volume>, <fpage>537</fpage>. <pub-id pub-id-type="doi">10.1186/s13063-019-3646-3</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Antidepressant and Immunosuppressive Activities of Two Polysaccharides from Poria Cocos (Schw.) Wolf</article-title>. <source>Int. J.&#x20;Biol. Macromolecules</source> <volume>120</volume>, <fpage>1696</fpage>&#x2013;<lpage>1704</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.09.171</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Menzies</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Auwerx</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Role of Mitochondria in Stem Cell Fate and Aging</article-title>. <source>Development</source> <volume>145</volume>. <pub-id pub-id-type="doi">10.1242/dev.143420</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.-l.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>J.-w.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>W.-l.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>L.-p.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Traditional Uses, Phytochemistry, and Pharmacology of Atractylodes Macrocephala Koidz.: A Review</article-title>. <source>J.&#x20;Ethnopharmacology</source> <volume>226</volume>, <fpage>143</fpage>&#x2013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2018.08.023</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>